EMAIL THIS PAGE TO A FRIEND

Biochemistry

Hypoxia and reoxygenation induce endothelial nitric oxide synthase uncoupling in endothelial cells through tetrahydrobiopterin depletion and S-glutathionylation.


PMID 24758136

Abstract

Ischemia-reperfusion injury is accompanied by endothelial hypoxia and reoxygenation that trigger oxidative stress with enhanced superoxide generation and diminished nitric oxide (NO) production leading to endothelial dysfunction. Oxidative depletion of the endothelial NO synthase (eNOS) cofactor tetrahydrobiopterin can trigger eNOS uncoupling, in which the enzyme generates superoxide rather than NO. Recently, it has also been shown that oxidative stress can induce eNOS S-glutathionylation at critical cysteine residues of the reductase site that serves as a redox switch to control eNOS coupling. While superoxide can deplete tetrahydrobiopterin and induce eNOS S-glutathionylation, the extent of and interaction between these processes in the pathogenesis of eNOS dysfunction in endothelial cells following hypoxia and reoxygenation remain unknown. Therefore, studies were performed on endothelial cells subjected to hypoxia and reoxygenation to determine the severity of eNOS uncoupling and the role of cofactor depletion and S-glutathionylation in this process. Hypoxia and reoxygenation of aortic endothelial cells triggered xanthine oxidase-mediated superoxide generation, causing both tetrahydrobiopterin depletion and S-glutathionylation with resultant eNOS uncoupling. Replenishing cells with tetrahydrobiopterin along with increasing intracellular levels of glutathione greatly preserved eNOS activity after hypoxia and reoxygenation, while targeting either mechanism alone only partially ameliorated the decrease in NO. Endothelial oxidative stress, secondary to hypoxia and reoxygenation, uncoupled eNOS with an altered ratio of oxidized to reduced glutathione inducing eNOS S-glutathionylation. These mechanisms triggered by oxidative stress combine to cause eNOS dysfunction with shift of the enzyme from NO to superoxide production. Thus, in endothelial reoxygenation injury, normalization of both tetrahydrobiopterin levels and the glutathione pool are needed for maximal restoration of eNOS function and NO generation.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

D6518
Diethylenetriaminepentaacetic acid, ≥99% (titration)
C14H23N3O10
D1133
Diethylenetriaminepentaacetic acid, ≥98% (titration)
C14H23N3O10
32319
Diethylenetriaminepentaacetic acid, for complexometry, ≥99.0%
C14H23N3O10
59706
Iodine Solution (0.02M in THF/pyridine/H2O 70:20:10), for DNA synthesis
I2
95437
L-Cysteine, certified reference material, TraceCERT®
C3H7NO2S
M9429
Menadione, meets USP testing specifications
C11H8O2
1381006
Menadione, United States Pharmacopeia (USP) Reference Standard
C11H8O2
M0300000
Menadione, European Pharmacopoeia (EP) Reference Standard
C11H8O2
PHR1411
Menadione, Pharmaceutical Secondary Standard; Certified Reference Material
C11H8O2
47775
Menadione (K3), analytical standard
C11H8O2
O6881
Oxypurinol, ≥98% (HPLC)
C5H4N4O2
42688
Oxypurinol, analytical standard
C5H4N4O2
746428
Potassium iodide, anhydrous, free-flowing, Redi-Dri, ACS reagent, ≥99%
IK
793582
Potassium iodide, anhydrous, free-flowing, Redi-Dri, ReagentPlus®, 99%
IK
60399
Potassium iodide, BioUltra, ≥99.5% (AT)
IK
P2963
Potassium iodide, BioXtra, ≥99.0%
IK
P8166
Potassium iodide, plant cell culture tested
IK
60422
Potassium iodide, tested according to Ph Eur
IK
429422
Potassium iodide, anhydrous, beads, −10 mesh, 99.998% trace metals basis
IK
204102
Potassium iodide, ≥99.99% trace metals basis
IK
PHR1360
Potassium Iodide, Pharmaceutical Secondary Standard; Certified Reference Material
IK
O4003
Sodium octyl sulfate, ≥95%
C8H17NaO4S
75073
Sodium octyl sulfate, for ion pair chromatography, LiChropur, ≥99.0% (T)
C8H17NaO4S